AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Dark Side of Drug Pricing
This chapter exposes the complex and often troubling realities of drug pricing, focusing on insulin and GLP-1 medications. It illustrates the financial maneuvers of pharmaceutical companies, the impact of Pharmacy Benefit Managers, and the ethical concerns surrounding corporate practices in the industry. Additionally, it critiques the regulatory challenges facing medical devices, shedding light on the risks of inadequate safety studies and the potential dangers posed to patients.